Literature DB >> 12892962

Neuropathological assessment of artemether-treated severe malaria.

T T Hien1, G D H Turner, N T H Mai, N H Phu, D Bethell, W F Blakemore, J B Cavanagh, A Dayan, I Medana, R O Weller, N P J Day, N J White.   

Abstract

In animals, high doses of intramuscular artemether and artemotil have been shown to cause an unusual pattern of selective damage to certain brainstem nuclei, especially those implicated in hearing and balance. We aimed to investigate whether a similar pattern arises in human adults. We examined the brainstems of adults who died after treatment with high dose artemether or quinine for severe falciparum malaria for evidence of a pattern of selective neuronal damage. Neuropathological findings were similar in recipients of quinine (n=15) and artemether (n=6; total artemether doses received 4-44 mg/kg). No evidence was recorded for artemether-induced neurotoxic effects.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12892962     DOI: 10.1016/s0140-6736(03)13974-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  10 in total

1.  Meningeal inflammation increases artemether concentrations in cerebrospinal fluid in Papua New Guinean children treated with intramuscular artemether.

Authors:  Laurens Manning; Moses Laman; Madhu Page-Sharp; Sam Salman; Ilomo Hwaiwhanje; Namar Morep; Peter Siba; Ivo Mueller; Harin A Karunajeewa; Timothy M E Davis
Journal:  Antimicrob Agents Chemother       Date:  2011-08-22       Impact factor: 5.191

2.  Randomized, prospective, three-arm study to confirm the auditory safety and efficacy of artemether-lumefantrine in Colombian patients with uncomplicated Plasmodium falciparum malaria.

Authors:  Gabriel Carrasquilla; Clemencia Barón; Edwin M Monsell; Marc Cousin; Verena Walter; Gilbert Lefèvre; Oliver Sander; Laurel M Fisher
Journal:  Am J Trop Med Hyg       Date:  2012-01       Impact factor: 2.345

Review 3.  Artemisinins.

Authors:  C J Woodrow; R K Haynes; S Krishna
Journal:  Postgrad Med J       Date:  2005-02       Impact factor: 2.401

4.  Disposition of artesunate and dihydroartemisinin after administration of artesunate suppositories in children from Papua New Guinea with uncomplicated malaria.

Authors:  Harin A Karunajeewa; Kenneth F Ilett; Kitiya Dufall; Adedayo Kemiki; Moses Bockarie; Michael P Alpers; P Hugh Barrett; Paolo Vicini; Timothy M E Davis
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

5.  Coma in fatal adult human malaria is not caused by cerebral oedema.

Authors:  Isabelle M Medana; Nicholas P J Day; Navakanit Sachanonta; Nguyen T H Mai; Arjen M Dondorp; Emsri Pongponratn; Tran T Hien; Nicholas J White; Gareth D H Turner
Journal:  Malar J       Date:  2011-09-17       Impact factor: 2.979

6.  Defining Surrogate Endpoints for Clinical Trials in Severe Falciparum Malaria.

Authors:  Atthanee Jeeyapant; Hugh W Kingston; Katherine Plewes; Richard J Maude; Josh Hanson; M Trent Herdman; Stije J Leopold; Thatsanun Ngernseng; Prakaykaew Charunwatthana; Nguyen Hoan Phu; Aniruddha Ghose; M Mahtab Uddin Hasan; Caterina I Fanello; Md Abul Faiz; Tran Tinh Hien; Nicholas P J Day; Nicholas J White; Arjen M Dondorp
Journal:  PLoS One       Date:  2017-01-04       Impact factor: 3.240

7.  Optimal 10-Aminoartemisinins With Potent Transmission-Blocking Capabilities for New Artemisinin Combination Therapies-Activities Against Blood Stage P. falciparum Including PfKI3 C580Y Mutants and Liver Stage P. berghei Parasites.

Authors:  Ho Ning Wong; Vivian Padín-Irizarry; Mariëtte E van der Watt; Janette Reader; Wilna Liebenberg; Lubbe Wiesner; Peter Smith; Korina Eribez; Elizabeth A Winzeler; Dennis E Kyle; Lyn-Marie Birkholtz; Dina Coertzen; Richard K Haynes
Journal:  Front Chem       Date:  2020-01-10       Impact factor: 5.221

8.  The neurological assessment in young children treated with artesunate monotherapy or artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria.

Authors:  Michael T Ambler; Lilly M Dubowitz; Ratree Arunjerdja; Eh Paw Hla; Kyaw Lay Thwai; Jacher Viladpainguen; Pratap Singhasivanon; Christine Luxemburger; François Nosten; Rose McGready
Journal:  Malar J       Date:  2009-09-02       Impact factor: 2.979

9.  Erythropoietin and its receptors in the brainstem of adults with fatal falciparum malaria.

Authors:  Isabelle M Medana; Nicholas P J Day; Tran Tinh Hien; Nicholas J White; Gareth D H Turner
Journal:  Malar J       Date:  2009-11-22       Impact factor: 2.979

10.  Ototoxicity of artemether/lumefantrine in the treatment of falciparum malaria: a randomized trial.

Authors:  Robert Gürkov; Teferi Eshetu; Isabel Barreto Miranda; Nicole Berens-Riha; Yoseph Mamo; Tsinuel Girma; Eike Krause; Michael Schmidt; John-Martin Hempel; Thomas Löscher
Journal:  Malar J       Date:  2008-09-16       Impact factor: 2.979

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.